search innovation
Innovative scintillators for medical diagnostics
keywords: computer tomography (CT), positron emission tomography (PET), single-photon emission computed tomography (SPECT), polymer scintillators
offer number: P-225, P-403
The subject of the offer is technology of vinyl monomers block polymerization in a specialized reactor to produce polymer scintillators.

Scintillators are chemical substances whose particles, when subjected to effects of ionising radiation, reach an excited state or undergo ionisation, and their return to the basic state results in the emission of photons with specifi c wavelengths. They are main part of scanners used in tomography technologies, but presently, annihilation gamma quanta are measured by scintillators built from expensive, inorganic crystals.
Thus signifi cant costs reduction of the CT scanner by replacing expensive inorganic scintillators with cheap polymer ones is an important problem in cancer diagnostics and monitoring of anticancer therapy. Polymer scintillators are produced by dissolving scintillating additions in refi ned liquid monomer and by initiating polymerization reaction, but to conduct the process safely and to obtain a homogeneous polymer product it is necessary to design a specialized reactor.
As the main part of scanners used for computer tomography (CT), positron emission tomography (PET) and single-photon emission computed tomography (SPECT).

Offered IP relates to:
- technology of quite simple and inexpensive synthesis of polymeric scintillators whose scintillating features are similar to characteristics of available wavelength shifters. This technology is patented in the area of Poland (patent no. PL 227854, granted 7/09/2017), EPO and USA;
- technology of construction of the reactor which enables obtaining a homogeneous polymer in a form of long strips or plates without optical heterogeneities. This technology is subject to a patent application in the area of Poland and abroad (with priority date 28/04/2018).
Further development of the invention is under progress at Jagiellonian University.

Logos od European Funds, Republic of Poland, Inkubator Innowacyjności 2.0, European Union
field of science: physics, health sciences
forms of protection: patent, patent application
technological maturity: demanding R & D
property rights: Jagiellonian University
variants of cooperation: license, comercial contract research, sale

information / broker of Jagiellonian University

name and surname: Agata Błaszczyk-Pasteczka
phone number: +48 12 664 42 12, +48 506 006 553
latest information
Big Pharma Day online
Big Pharma Day online is an industry meeting on the development of drug projects, organized by CTT CITTRU, happening on March 25, 2021. The event will include expert presentations and individual meetings.
A new, effective method for obtaining common ash cuttings
Discover a new technology for obtaining cuttings of common ash developed by the interdisciplinary research team from the Jagiellonian University and the University of Agriculture in Krakow.
Development of biotization technology for commercial and ecological production of berry fruits
The scientific team from Jagiellonian University developed an inoculum that stimulates seedling growth.
Our employees
Innovation Forum KrakówKlaster Lifescience KrakówWolves SummitPACTTJagiellońskie Centrum Innowacji
Centre for Technology Transfer CITTRU
Jagiellonian University in Kraków - POLAND
ul. Bobrzyńskiego 14,
30-348 Kraków

+48 12 664 42 00
Fundusze EuropejskieMNiSWInkubator InnowacyjnościUnia Europejska